Appealing An FDA Device Decision? Proposed Rule Clarifies Framework
Executive Summary
US FDA has issued a proposed rule that explains what decisions are eligible for supervisory review, and sets a timeframe for filing appeals.
You may also be interested in...
US FDA Shelves Proposal To Mandate Home-Use Device E-Labeling
A controversial 2016 proposed rule that would have required manufacturers of many class II and class III home-use devices to electronically submit device labeling information to US FDA will not be finalized, the agency affirmed in the Oct. 17 HHS Unified Agenda document. The agency also signaled plans to imminently finalize a broad device classification rule, and other updates.
Recall Of Valiant Navion Could Cost Medtronic $40M
The company ordered the recall after three stent fractures and a death occurred in an 89-participant clinical trial.
Pulse Oximeters May Be Less Accurate For Dark-Skinned People, FDA Warns
The US agency’s safety alert says the devices, which measure blood oxygen levels, may be less accurate in patients with darker skin tones.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: